KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
作者信息
Olthof Pim B, Buettner Stefan, Andreatos Nikolaos, Wang Jane, Løes Inger Marie, Wagner Doris, Sasaki Kazunari, Macher-Beer Andrea, Kamphues Carsten, Pozios Ioannis, Seeliger Hendrik, Morioka Daisuke, Imai Katsunori, Kaczirek Klaus, Pawlik Timothy M, Poultsides George, Burkhart Richard, Endo Itaru, Baba Hideo, Kornprat Peter, Aucejo Federico N, Lønning Per Eystein, Beyer Katharina, Weiss Matthew J, Wolfgang Christopher L, Kreis Martin E, Margonis Georgios A
机构信息
Department of Surgery, Erasmus University, Rotterdam, the Netherlands.
Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Br J Surg. 2022 Aug 16;109(9):804-807. doi: 10.1093/bjs/znac147.
Abstract
摘要
相似文献
1
KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.结直肠癌肝转移中的KRAS改变：转向外显子、密码子和点突变。
Br J Surg. 2022 Aug 16;109(9):804-807. doi: 10.1093/bjs/znac147.
2
Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.评论：结直肠癌肝转移中的KRAS改变：转向外显子、密码子和点突变。
Br J Surg. 2022 Oct 14;109(11):e121. doi: 10.1093/bjs/znac256.
3
Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.作者对《关于结直肠癌肝转移中KRAS改变：转向外显子、密码子和点突变的评论》的回应
Br J Surg. 2022 Oct 14;109(11):e122. doi: 10.1093/bjs/znac257.
4
KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.在结直肠癌肺转移瘤切除术后，KRAS基因第2外显子13密码子突变较12密码子突变的预后更好。
Oncotarget. 2017 Jan 10;8(2):2514-2524. doi: 10.18632/oncotarget.13697.
5
Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis.并非所有不可切除结直肠癌肝转移患者的 Kirsten 鼠肉瘤病毒致癌基因同源突变都预示着不良预后。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039131. doi: 10.1177/15330338211039131.
6
Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?结直肠癌肝转移更常为超野生型。是否应基于转移部位基因分型进行治疗？
Target Oncol. 2015 Sep;10(3):415-21. doi: 10.1007/s11523-014-0346-5. Epub 2014 Nov 26.
7
Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.第 13 密码子 KRAS 突变可预测行肝切除术的结直肠癌肝转移患者的复发模式。
Cancer. 2016 Sep 1;122(17):2698-707. doi: 10.1002/cncr.30085. Epub 2016 May 31.
8
Concomitant RAS and BRAF mutation in colorectal cancer - A report of 7 cases.结直肠癌中RAS和BRAF基因的同时突变——7例报告
Indian J Cancer. 2019 Apr-Jun;56(2):176-179. doi: 10.4103/ijc.IJC_430_18.
9
RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.越南结直肠癌中不同通路的 RAS/RAF 突变及其与表观遗传改变的关联。
Pathol Res Pract. 2020 Apr;216(4):152898. doi: 10.1016/j.prp.2020.152898. Epub 2020 Feb 17.
10
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.KRAS外显子2突变作为晚期结直肠癌临床实践中预后指标的单机构研究
Mol Diagn Ther. 2016 Feb;20(1):65-74. doi: 10.1007/s40291-015-0178-8.
引用本文的文献
1
Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis.肿瘤及循环基因组格局揭示结直肠癌肝转移的生存差异
Transl Oncol. 2025 May;55:102379. doi: 10.1016/j.tranon.2025.102379. Epub 2025 Apr 3.
2
Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases.KRAS 点突变与接受结直肠癌肝转移根治性切除患者生存率的相关性
Ann Surg Oncol. 2025 Apr;32(4):2425-2434. doi: 10.1245/s10434-024-16822-4. Epub 2025 Jan 16.
3
Unveiling the role of in Chinese colorectal cancer patients: a positive influence on tumor mutational burden.揭示[具体内容]在中国结直肠癌患者中的作用：对肿瘤突变负荷的积极影响。 （原文中“Unveiling the role of ”后缺少具体内容）
Transl Cancer Res. 2024 Sep 30;13(9):4752-4762. doi: 10.21037/tcr-24-600. Epub 2024 Sep 25.
4
Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study.评估与切除的结直肠癌肝转移预后不良相关的生物学和临床病理因素组合：一项外部验证研究
Ann Surg Oncol. 2025 Jan;32(1):408-417. doi: 10.1245/s10434-024-16319-0. Epub 2024 Oct 8.
5
Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview.手术治疗的结直肠癌肝转移灶中的体细胞突变：概述。
Cells. 2024 Apr 14;13(8):679. doi: 10.3390/cells13080679.
6
Precision surgery for colorectal liver metastases: Current knowledge and future perspectives.结直肠癌肝转移的精准手术：当前认知与未来展望
Ann Gastroenterol Surg. 2022 Jun 27;6(5):606-615. doi: 10.1002/ags3.12591. eCollection 2022 Sep.
7
Gene Alterations, Mediators, and Artificial Intelligence in Colorectal Liver Metastases.结直肠癌肝转移中的基因改变、介体和人工智能。
Cells. 2022 Jul 15;11(14):2205. doi: 10.3390/cells11142205.
本文引用的文献
1
KRAS Inhibition with Sotorasib in Advanced Solid Tumors.索托拉西布治疗晚期实体瘤的 KRAS 抑制作用。
N Engl J Med. 2020 Sep 24;383(13):1207-1217. doi: 10.1056/NEJMoa1917239. Epub 2020 Sep 20.
2
Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.结直肠癌肝转移切除术后RAS突变位置与肿瘤学结局的相关性
Ann Surg Oncol. 2021 Feb;28(2):817-825. doi: 10.1245/s10434-020-08862-3. Epub 2020 Jul 18.
3
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.BRAF 突变与手术治疗转移性结直肠癌肝转移患者生存和复发的关系。
JAMA Surg. 2018 Jul 18;153(7):e180996. doi: 10.1001/jamasurg.2018.0996.
4
Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.RAS癌基因上的突变位置影响结直肠肝转移瘤切除术后的病理特征和生存情况。
Cancer. 2017 Feb 15;123(4):568-575. doi: 10.1002/cncr.30351. Epub 2016 Oct 13.
5
Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.结直肠癌肝转移肝切除术后KRAS状态的预后意义因原发性结直肠癌肿瘤位置而异。
Ann Surg Oncol. 2016 Oct;23(11):3736-3743. doi: 10.1245/s10434-016-5361-6. Epub 2016 Jun 28.
6
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.结直肠癌肝转移切除术后 KRAS 突变与生存的荟萃分析。
Br J Surg. 2015 Sep;102(10):1175-83. doi: 10.1002/bjs.9870. Epub 2015 Jul 21.
7
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.BRAF 密码子 594 和 596 突变鉴定出转移性结直肠癌具有良好预后的新分子亚型。
Ann Oncol. 2015 Oct;26(10):2092-7. doi: 10.1093/annonc/mdv290. Epub 2015 Jul 7.
8
Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.KRAS基因第12密码子特定突变与结直肠癌肝转移之间的关联
JAMA Surg. 2015 Aug;150(8):722-9. doi: 10.1001/jamasurg.2015.0313.
9
RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.RAS 基因突变状态可预测行肝切除术的结直肠癌肝转移患者的生存和复发模式。
Ann Surg. 2013 Oct;258(4):619-26; discussion 626-7. doi: 10.1097/SLA.0b013e3182a5025a.
10
Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.KRAS 密码子 12 和 13 中的特定突变与 1075 例 BRAF 野生型结直肠癌患者的预后。
Clin Cancer Res. 2012 Sep 1;18(17):4753-63. doi: 10.1158/1078-0432.CCR-11-3210. Epub 2012 Jul 2.
Zotero 插件